Palisade Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$322K Hold
2,900
0.01% 349
2025
Q1
$325K Hold
2,900
0.01% 357
2024
Q4
$268K Buy
2,900
+300
+12% +$27.7K 0.01% 353
2024
Q3
$218K Buy
+2,600
New +$218K 0.01% 358
2024
Q1
Sell
-3,200
Closed -$259K 366
2023
Q4
$259K Hold
3,200
0.01% 359
2023
Q3
$240K Hold
3,200
0.01% 355
2023
Q2
$247K Hold
3,200
0.01% 352
2023
Q1
$266K Hold
3,200
0.01% 367
2022
Q4
$275K Buy
+3,200
New +$275K 0.01% 377
2022
Q1
Sell
-3,200
Closed -$232K 427
2021
Q4
$232K Sell
3,200
-300
-9% -$21.8K ﹤0.01% 408
2021
Q3
$244K Hold
3,500
0.01% 390
2021
Q2
$241K Hold
3,500
0.01% 385
2021
Q1
$226K Hold
3,500
0.01% 368
2020
Q4
$204K Sell
3,500
-150
-4% -$8.74K 0.01% 373
2020
Q3
$231K Hold
3,650
0.01% 372
2020
Q2
$281K Hold
3,650
0.01% 356
2020
Q1
$273K Hold
3,650
0.01% 379
2019
Q4
$237K Hold
3,650
0.01% 389
2019
Q3
$231K Hold
3,650
0.01% 402
2019
Q2
$247K Hold
3,650
0.01% 387
2019
Q1
$237K Hold
3,650
0.01% 412
2018
Q4
$228K Sell
3,650
-4,585
-56% -$286K 0.01% 424
2018
Q3
$636K Hold
8,235
0.02% 386
2018
Q2
$583K Hold
8,235
0.02% 377
2018
Q1
$621K Sell
8,235
-1,000
-11% -$75.4K 0.02% 371
2017
Q4
$662K Buy
9,235
+1,000
+12% +$71.7K 0.02% 350
2017
Q3
$667K Sell
8,235
-565
-6% -$45.8K 0.02% 353
2017
Q2
$623K Sell
8,800
-1,500
-15% -$106K 0.02% 363
2017
Q1
$700K Sell
10,300
-300
-3% -$20.4K 0.03% 342
2016
Q4
$759K Hold
10,600
0.03% 357
2016
Q3
$839K Buy
10,600
+4,350
+70% +$344K 0.03% 434
2016
Q2
$521K Sell
6,250
-34
-0.5% -$2.83K 0.02% 466
2016
Q1
$577K Sell
6,284
-10,376
-62% -$953K 0.02% 457
2015
Q4
$1.69M Buy
16,660
+160
+1% +$16.2K 0.05% 361
2015
Q3
$1.62M Buy
16,500
+3,500
+27% +$344K 0.05% 366
2015
Q2
$1.52M Hold
13,000
0.04% 374
2015
Q1
$1.28M Buy
13,000
+7,520
+137% +$738K 0.03% 375
2014
Q4
$517K Buy
5,480
+500
+10% +$47.2K 0.01% 426
2014
Q3
$530K Buy
+4,980
New +$530K 0.01% 422